|
Early-Career Investigator Awards (3x winners) |
|
|
Yongcong Fang, PhD |
Tsinghua University, China |
|
|
|
|
Fang Yongcong is an Assistant Professor in the Department of Mechanical Engineering at Tsinghua University. He earned both his Bachelor's (2013) and Ph.D. (2020) degrees in Engineering from Tsinghua, followed by postdoctoral research in the same department from 2021 to 2022. In 2023, he was appointed as a Research Assistant Professor. Dr. Fang's research centers on 3D bioprinting and cardiac regeneration, with a focus on functional bioinks and advanced biomanufacturing technologies. Dr. Fang has published 27 papers, including 15 as the first or corresponding author in leading journals such as Advanced Materials (2 papers), Materials Today, Advanced Functional Materials, and Advanced Science. His work has garnered 780 citations on Google Scholar, with one first-author paper recognized as an ESI Highly Cited Paper and two featured as cover articles. His research has also been highlighted by MIT Technology Review and CCTV News. His work is supported by the National Natural Science Foundation and the Ministry of Science and Technology's Key Research Projects. He serves as a Youth Committee Member of the Additive Manufacturing Division of the Chinese Society of Mechanical Engineering and is a Young Editorial Board Member and guest editor for several prestigious journals such as The Innovation. In 2023, he was selected for the Beijing Association for Science and Technology’s Young Talent Support Program (2023-2025). |
|
|
|
|
Lana Van Damme, MD, PhD |
Ghent University, Belgum |
|
|
|
|
Dr. Lana Van Damme is a distinguished PhD graduate specializing in biomaterials and tissue engineering, with a focus on adipose tissue engineering and minimally invasive breast reconstruction. She earned her bachelor's and master's degrees in medicine at Ghent University, where she developed a strong foundation in clinical practice and patient care. Currently, she serves as the Chief Scientific Officer of the spin-off company 4Tissue and works as a full-time postdoctoral researcher at Ghent University under the mentorship of Prof. Sandra Van Vlierberghe.
Throughout her PhD, Dr. Van Damme has demonstrated exceptional productivity and impact, as evidenced by numerous publications in leading journals such as Critical Care, Acta Biomaterialia, and Biomacromolecules. Her research has significantly advanced the field of adipose tissue engineering, opening new avenues for future studies, which is reflected in the high citation rates of her work.
In addition to her research accomplishments, Dr. Van Damme has been instrumental in translating academic findings into practical applications through her leadership in 4Tissue, showcasing her ability to bridge the gap between theory and industry. Her excellence has been recognized with several prestigious awards, including the Julia Pollack Award in 2024. |
|
|
|
|
Bram Soliman, PhD |
University of New South Wales, Australia |
|
|
|
|
Bram Soliman is a Postdoctoral Researcher (2 years post PhD) at the University of New South Wales, Australia. He completed his Ph.D. at the University of Otago, New Zealand, under the primary supervision of Associate Professor Khoon Lim on designing biofabrication strategies for the simultaneous control over macro- and microenvironment physical features in engineered tissues. For this work, Dr. Soliman was recognized with the Division of Health Sciences Award for Outstanding Ph.D. Thesis. His current research currently focusses on the developing reductionist in vitro models to investigate the roles of cell-cell and cell-matrix interactions in breast cancer drug resistance and metastasis. Dr. Soliman has published 14 papers (6 first author) in highly rated journals including Advanced Materials, Biofabrication, Advanced Functional Materials, Advanced Healthcare Materials, Macromolecular Biosciences and Macromolecules (FWCI: 3.67; h-index 10; i10-index 10, > 500 citations). Dr. Soliman is passionate about advancing biofabrication through a multidisciplinary approach towards addressing biological hypotheses and tackle clinically relevant issues. He believes that biofabrication techniques provide excellent tools for addressing these questions, whilst technological developments in these techniques. |
|
|